Simultaneous delivery of cytotoxic and biologic therapeutics using nanophotoactivatable liposomes enhances treatment efficacy in a mouse model of pancreatic cancer

Nanomedicine: Nanotechnology, Biology and Medicine - Tập 12 - Trang 223-234 - 2016
Shifalika Tangutoori1, Bryan Q. Spring1, Zhiming Mai1, Akilan Palanisami1, Lawrence B. Mensah1, Tayyaba Hasan1,2
1Wellman Center for Photomedicine, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA
2Harvard-MIT Division of Health Science and Technology, Boston MA, USA

Tài liệu tham khảo

Siegel, 2015, Cancer statistics, 2015, CA Cancer J Clin, 65, 5, 10.3322/caac.21254 2009 Bardeesy, 2002, Pancreatic cancer biology and genetics, Nat Rev Cancer, 2, 897, 10.1038/nrc949 Bardeesy, 2005, Molecular signaling pathways in pancreatic cancer, 43 Kessel, 1992, Porphyrin photosensitization of multiresistant cell types, Photochem Photobiol, 55, 397, 10.1111/j.1751-1097.1992.tb04253.x Canti, 1995, Efficacy of photodynamic therapy against doxorubicin-resistant murine tumors, Cancer Lett, 93, 255, 10.1016/0304-3835(95)03818-H Duska, 1999, Combination photoimmunotherapy and cisplatin: effects on human ovarian cancer ex vivo, J Natl Cancer Inst, 91, 1557, 10.1093/jnci/91.18.1557 Preise, 2003, Bypass of tumor drug resistance by antivascular therapy, Neoplasia, 5, 475, 10.1016/S1476-5586(03)80031-3 Holt, 2006, A cationic chalcogenoxanthylium photosensitizer effective in vitro in chemosensitive and multidrug-resistant cells, Bioorg Med Chem, 14, 8635, 10.1016/j.bmc.2006.08.023 Xie, 2009, Synergetic anticancer effect of combined gemcitabine and photodynamic therapy on pancreatic cancer in vivo, World J Gastroenterol, 15, 737, 10.3748/wjg.15.737 Mikvy, 1997, Photodynamic therapy of a transplanted pancreatic cancer model using meta-tetrahydroxyphenylchlorin (mTHPC), Br J Cancer, 96, 713, 10.1038/bjc.1997.451 Hajri, 1999, Human pancreatic carcinoma cells are sensitive to photodynamic therapy in vitro and in vivo, Br J Surg, 86, 899, 10.1046/j.1365-2168.1999.01132.x Bown, 2002, Photodynamic therapy for cancer of the pancreas, Gut, 50, 549, 10.1136/gut.50.4.549 Ayaru, 2005, Photodynamic therapy for pancreatic and biliary tract carcinoma, Int J Gastrointest Cancer, 35, 1, 10.1385/IJGC:35:1:001 Fan, 2007, Photodynamic therapy for pancreatic cancer, Pancreas, 34, 385, 10.1097/mpa.0b013e3180439c50 Celli, 2011, Verteporfin-based photodynamic therapy overcomes gemcitabine insensitivity in a panel of pancreatic cancer cell lines, Lasers Surg Med, 43, 565, 10.1002/lsm.21093 Huggett, 2014, Phase I/II study of verteporfin photodynamic therapy in locally advanced pancreatic cancer, Br J Cancer, 110, 1698, 10.1038/bjc.2014.95 Gorski, 1999, Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation, Cancer Res, 59, 3374 Abdollahi, 2003, SU5416 and SU6668 attenuate the angiogenic effects of radiation-induced tumor cell growth factor production and amplify the direct anti-endothelial action of radiation in vitro, Cancer Res, 63, 3755 Tran, 2002, A role for survivin in chemoresistance of endothelial cells mediated by VEGF, Proc Natl Acad Sci U S A, 99, 4349, 10.1073/pnas.072586399 Wild, 2004, Carboplatin selectively induces the VEGF stress response in endothelial cells: potentiation of antitumor activity by combination treatment with antibody to VEGF, Int J Cancer, 110, 343, 10.1002/ijc.20100 Justinger, 2008, Increased growth factor expression after hepatic and pancreatic resection, Oncol Rep, 20, 1527 Kosharskyy, 2006, A mechanism-based combination therapy reduces local tumor growth and metastasis in an orthotopic model of prostate cancer, Cancer Res, 66, 10953, 10.1158/0008-5472.CAN-06-1793 Chang, 2008, In vivo optical molecular imaging of vascular endothelial growth factor for monitoring cancer treatment, Clin Cancer Res, 14, 4146, 10.1158/1078-0432.CCR-07-4536 Chen, 2006, Tumor vascular permeabilization by vascular-targeting photosensitization: effects, mechanism, and therapeutic implications, Clin Cancer Res, 12, 917, 10.1158/1078-0432.CCR-05-1673 Mallidi, 2015, Prediction of tumor recurrence and therapy monitoring using ultrasound-guided photoacoustic imaging, Theranostics, 5, 289, 10.7150/thno.10155 Ferrario, 2000, Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma, Cancer Res, 60, 4066 Gomer, 2006, Photodynamic therapy: combined modality approaches targeting the tumor microenvironment, Lasers Surg Med, 38, 516, 10.1002/lsm.20339 Solban, 2006, Mechanistic investigation and implications of photodynamic therapy induction of vascular endothelial growth factor in prostate cancer, Cancer Res, 66, 5633, 10.1158/0008-5472.CAN-06-0604 Jiang, 2008, Combination therapy with antiangiogenic treatment and photodynamic therapy for the nude mouse bearing U87 glioblastoma, Photochem Photobiol, 84, 128 Allen, 1997, Liposomes. Opportunities in drug delivery, Drugs, 54, 8, 10.2165/00003495-199700544-00004 Campbell, 2002, Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors, Cancer Res, 62, 6831 Drummond, 1999, Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors, Pharmacol Rev, 51, 691 Sengupta, 2005, Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system, Nature, 436, 568, 10.1038/nature03794 Fu, 2014, Promises and pitfalls of intracellular delivery of proteins, Bioconjug Chem, 25, 1602, 10.1021/bc500320j Crielaard, 2012, Liposomes as carriers for colchicine-derived prodrugs: vascular disrupting nanomedicines with tailorable drug release kinetics, Eur J Pharm Sci, 45, 429, 10.1016/j.ejps.2011.08.027 Campbell, 2001, Influence of cationic lipids on the stability and membrane properties of paclitaxel-containing liposomes, J Pharm Sci, 90, 1091, 10.1002/jps.1063 Tangutoori, 2014, Repurposing an erstwhile cancer drug: a quantitative and therapeutic evaluation of alternative nanosystems for the delivery of colchicine to solid tumors, J Cancer Sci Ther, 6, 236, 10.4172/1948-5956.1000277 Loura, 2008, Effects of fluorescent probe NBD-PC on the structure, dynamics and phase transition of DPPC. A molecular dynamics and differential scanning calorimetry study, Biochim Biophys Acta, 1778, 491, 10.1016/j.bbamem.2007.10.022 Denekamp, 1999, The tumour microcirculation as a target in cancer therapy: a clearer perspective, Eur J Clin Invest, 29, 733, 10.1046/j.1365-2362.1999.00558.x Dokka, 2000, Oxygen radical-mediated pulmonary toxicity induced by some cationic liposomes, Pharm Res, 17, 521, 10.1023/A:1007504613351 Filion, 1998, Major limitations in the use of cationic liposomes for DNA delivery, Int J Pharm, 120, 159, 10.1016/S0378-5173(97)00423-7 Lorgis, 2012, Influence of localization of primary tumor on effectiveness of 5-fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) in patients with metastatic pancreatic adenocarcinoma: a retrospective study, Anticancer Res, 32, 4125 Assaf, 2011, 5-Fluorouracil/leucovorin combined with irinotecan and oxaliplatin (FOLFIRINOX) as second-line chemotherapy in patients with metastatic pancreatic adenocarcinoma, Oncology, 80, 301, 10.1159/000329803 Francois, 2012, Phase I trial of gemcitabine combined with capecitabine and erlotinib in advanced pancreatic cancer: a clinical and pharmacological study, Chemotherapy, 58, 371, 10.1159/000343969 Mattiucci, 2013, Long-term analysis of gemcitabine-based chemoradiation after surgical resection for pancreatic adenocarcinoma, Ann Surg Oncol, 20, 423, 10.1245/s10434-012-2767-7 Hong, 2013, A phase 1 study of gemcitabine combined with dasatinib in patients with advanced solid tumors, Invest New Drugs, 31, 918, 10.1007/s10637-012-9898-3 Brell, 2012, Phase I trial of sunitinib and gemcitabine in patients with advanced solid tumors, Cancer Chemother Pharmacol, 70, 547, 10.1007/s00280-012-1936-5 Sweeney, 2010, A phase I study of sunitinib plus capecitabine in patients with advanced solid tumors, J Clin Oncol, 28, 4513, 10.1200/JCO.2009.26.9696 Celli, 2010, Imaging and photodynamic therapy: mechanisms, monitoring, and optimization, Chem Rev, 110, 2795, 10.1021/cr900300p Lindenmann, 2012, Individualized, multimodal palliative treatment of inoperable esophageal cancer: clinical impact of photodynamic therapy resulting in prolonged survival, Lasers Surg Med, 44, 189, 10.1002/lsm.22006 Lee, 2011, Photodynamic therapy: current evidence and applications in dermatology, Semin Cutan Med Surg, 30, 199, 10.1016/j.sder.2011.08.001 Chowdhary, 2003, Drug release characteristics of lipid based benzoporphyrin derivative, J Pharm Sci, 6, 13 Aveline, 1995, The effects of aggregation, protein binding and cellular incorporation on the photophysical properties of benzoporphyrin derivative monoacid ring A (BPDMA), J Photochem Photobiol B, 30, 161, 10.1016/1011-1344(95)07174-Z Spring, 2014, Selective treatment and monitoring of disseminated cancer micrometastases in vivo using dual-function, activatable immunoconjugates, Proc Natl Acad Sci U S A, 111, E933, 10.1073/pnas.1319493111 Rizvi, 2010, Synergistic enhancement of carboplatin efficacy with photodynamic therapy in a three-dimensional model for micrometastatic ovarian cancer, Cancer Res, 70, 9319, 10.1158/0008-5472.CAN-10-1783 You, 2011, VEGF and c-Met blockade amplify angiogenesis inhibition in pancreatic islet cancer, Cancer Res, 71, 4758, 10.1158/0008-5472.CAN-10-2527